BeiGene, a Hong Kong and Nasdaq-listed global, biotechnology company focused on developing affordable medicines, has priced an IPO on the Science and Technology Innovation Board (STAR Market) of the …
( read original story …)
The Shanghai News
BeiGene, a Hong Kong and Nasdaq-listed global, biotechnology company focused on developing affordable medicines, has priced an IPO on the Science and Technology Innovation Board (STAR Market) of the …
( read original story …)